Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 70.25

+0.1%

Nov 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (116)	2/24/2003 12:24:27 PM
From: Jibacoa	Read Replies (2) of 3722

MDCO I have been asked by Mike on another thread for some comments since my previous one last November. Message 18619682 Message 18249564 The stock on November 20 closed only the upper part of its up-gap on November 18 and has been able to remain on a moderately slanted UPTREND.<g> It needs to close above its January 16 H of 18.75, but on doing that it will make another 52wks. H and should probably be able to test the resistance at the 22 to 22.20 level from July 2001. The stock is presently trading at more than 13x book and 17x sales. Insiders that hold close to 70% of the shares reportedly have sold more than 10M shares in the last 6 months. However, the institutions that hold more than 290% of the float reportedly have bought more than 7M shares and there is a short position of more than 4M (about 34% of the float) which gives the possibility of a good "s.s" in the near future.<g> The article on Forbes about the heparin risks is favorable to MDCO since it says "Angiomax, which appeared to be as effective as heparin but safer in a recent clinical trial. As a result, Angiomax sales jumped more than 50% between the third and fourth quarters of 2002". (emphasis mine.<g>) siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next